Early- and Late-Stage Clinical Trials for the Spectrum of Alzheimer's Disease/Alzheimer's Disease-Related Dementias and Age-Related Cognitive Decline
- Award ceiling
- Not stated
- Closes
- Not stated
- Last verified
- 2026-10-22
Per-recipient award not stated for county governments, for profit organizations other than small businesses, independent school districts, native american tribal governments (federally recognized), native american tribal organizations (other than federally recognized tribal governments), nonprofits having a 501(c)(3) status with the irs, other than institutions of higher education, private institutions of higher education, public and state controlled institutions of higher education, public housing authorities/indian housing authorities, small businesses, state governments.
In one sentence
Early- and Late-Stage Clinical Trials for the Spectrum of Alzheimer's Disease/Alzheimer's Disease-Related Dementias and Age-Related Cognitive Decline does not state a per-recipient award amount, open to county governments, for profit organizations other than small businesses, independent school…
- Program pool (total)
- Not confirmedTotal across all awards in this programme. Not an amount any single applicant can receive.
- Award ceiling (per project)
- Not confirmed
- Award floor
- Not confirmed
- Typical award
- Not confirmed
- Deadline
- Not stated
- Deadline type
- Not stated
- Opens
- Aug 1, 2025
- Status
- Forecasted
- Eligible entities
- County governments · For profit organizations other than small businesses · Independent school districts · Native American tribal governments (Federally recognized) · Native American tribal organizations (other than Federally recognized tribal governments) · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · Private institutions of higher education · Public and State controlled institutions of higher education · Public housing authorities/Indian housing authorities · Small businesses · State governments
- Geography
- Not stated
- Matching funds
- No
- Disbursement
- Not confirmed
- Application effort
- Not confirmed
- Use of funds
- develop and implement early- to late-stage clinical trials of promising pharmacological and non-pharmacological interventions to prevent and/or treat the cognitive, behavioral, and neuropsychiatric changes associated with age-related cognitive decline and Alzheimer's disease (AD) and Alzheimer's disease-related dementias (ADRD) · enhance trial design and methods
- Currency
- USD
How much money is available?
Two different figures govern a programme and they are not interchangeable. The programme pool is what the funder has allocated across every award it will make this cycle. The award ceiling is the most one applicant can be granted.
Who can apply?
+1more
, State governmentsNot confirmed
Source field: applicant size limitNot confirmed
We store the structured fields above. Clause-by-clause text from the guidelines is not connected for this record.When does it close?
What can the money be used for?
2 categorysThe source’s own spending categories, and what is not parsed.
These categories come from the source's own classification. A line-item cost table, where the programme publishes one, lives in the guidelines and is not parsed for this record.
How hard is the application?
1 fieldEffort, match requirement and reimbursement, as the source stated them.
- Application effort
- Not confirmed
- Disbursement
- Not confirmed
- Matching funds
- No
What comparable notices state
291 recordsStated ceilings on open records in the same industry.
Among open records stored under Health & Human Services, 291 of 889 state an award ceiling. Those that do run:
- 25th percentile$357,500
- Median$600,000
- 75th percentile$1,500,000
A statistical estimate, not a prediction. It describes what a set of notices has published in this catalogue on the day you read it, and says nothing about what this programme will award. Records stating no ceiling are excluded rather than counted as zero, and the programme pool — what a funder has across every applicant — is a different column and is never mixed in.
Who has won this programme before?
11627 awardsAwards under the same assistance listing, not under this notice.
11627 federal awards on file under assistance listing 93.866, the programme this notice is published under. These are not awards made under this notice — a listing covers every year the programme runs, and awards under an open notice do not exist yet.
- $463,372,200REGENTS OF THE UNIVERSITY OF MICHIGANMI · FY1998
- $199,819,363NORTHERN CALIFORNIA INSTITUTE FOR RESEARCH AND EDUCATION, INC.CA · FY2004
- $148,130,300THE UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER AT FORT WORTHTX · FY2022
- $113,990,692TRUSTEES OF INDIANA UNIVERSITYIN · FY2002
- $109,670,101WASHINGTON UNIVERSITY, THEMO · FY2019
Common questions
3 questionsEvery answer is a stored field from this record. Questions the source did not answer are not asked.
- Who is eligible to apply?
- County governments, For profit organizations other than small businesses, Independent school districts, Native American tribal governments (Federally recognized), Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education, Private institutions of higher education, Public and State controlled institutions of higher education, Public housing authorities/Indian housing authorities, Small businesses, State governments.
- What can the funding be used for?
- develop and implement early- to late-stage clinical trials of promising pharmacological and non-pharmacological interventions to prevent and/or treat the cognitive, behavioral, and neuropsychiatric changes associated with age-related cognitive decline and Alzheimer's disease (AD) and Alzheimer's disease-related dementias (ADRD), enhance trial design and methods, as classified by the source.
- Is matching funding required?
- No. The source states that no matching funds are required.
AI summary of the source text
Optional. Every core field on this record is already above, free and complete.
AI summary of the source text
Studio reads this record’s stored eligibility and materials text and breaks it into separate points, each quoting the exact words it came from. It never writes application prose, never guesses at a field the source did not state, and never estimates anyone’s chances.
Included with Studio
Sign inWhat else is open
- Silvio O. Conte Centers for Basic Neuroscience or Translational Mental Health Research (P50 Clinical Trial Optional)Closes May 25, 2028Awards Not stated
- Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Clinical Trial Not Allowed)Closes Jun 12, 2028Awards Not stated
- Grants for Early Medical/Surgical Specialists' Transition to Aging Research (GEMSSTAR) (R03 Clinical Trial Optional)Closes Jul 16, 2028Awards up to $125,000
- Development of Candidate Medical Countermeasures (MCMs) and Technologies Against Radiological/Nuclear or Chemical Threats (U01 Clinical Trial Not Allowed)Closes Oct 9, 2028Awards Not stated
- Complex Integrated Multi-Component Projects in Aging Research (U19 Clinical Trial Optional)Closes Not statedAwards Not stated
- Novel Approaches to Advance Precision Aging and Cognitive HealthCloses Not statedAwards Not stated
A listing names the programme; a notice names one round of it. These are other rounds open now, not other years of this one.
- Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Clinical Trial Not Allowed)Closes Jun 12, 2028Awards Not stated
- Grants for Early Medical/Surgical Specialists' Transition to Aging Research (GEMSSTAR) (R03 Clinical Trial Optional)Closes Jul 16, 2028Awards up to $125,000
- Complex Integrated Multi-Component Projects in Aging Research (U19 Clinical Trial Optional)Closes Not statedAwards Not stated
- Novel Approaches to Advance Precision Aging and Cognitive HealthCloses Not statedAwards Not stated
- Illuminating AD/ADRD Genome to Enable Precision Genomic MedicineCloses Not statedAwards Not stated
- Understanding Cerebellar Contributions to Cognitive and Affective Functions in Aging and Alzheimer's Disease/Alzheimer's Disease-Related DementiasCloses Not statedAwards Not stated
The official page governs. If the source and this record disagree, the source is correct — programmes change their terms between our checks, so confirm every figure above before you apply.